InvestorsHub Logo
Followers 8
Posts 273
Boards Moderated 0
Alias Born 03/12/2007

Re: None

Friday, 08/02/2019 2:04:56 PM

Friday, August 02, 2019 2:04:56 PM

Post# of 233755
Trump Brings Hope to Black America With Bold Measures to End AIDS

https://www.newsmax.com/jackbrewer/hiv-aids-trump-black-america/2019/08/02/id/927030/

“There just may be a very innovative healthcare solution recently developed by CytoDyn. The company is one of only a few firms to be given “fast track” approval from the FDA, meaning their new drug, Leronlimab (PRO 140) could be approved by the end of this year. Leronlimab is the first self-administered therapy for HIV that has reached late-stage clinical development. It’s a major game changer for those living with HIV, because unlike most current therapies, it doesn’t require any pills.

“We have patients who have gone 18 months without any pills,” says Dr. Nader Pourhassan, CytoDyn CEO. “Some patients had up to seven pills a day, they put all of it away, and we are very proud of those results.” Recent clinical trials have shown that Leronlimab does not negatively affect normal immune functions, but it does block the HIV co-receptor on T-cells. These trials also found that using Leronlimab can significantly reduce viral burden in people infected with HIV.

CytoDyn and Leronlimab have been garnering major buzz in the news, they’ve even been noticed by actor Charlie Sheen, who was recently diagnosed with HIV, and has applied to be a part of CytoDyn’s trials. With blacks representing nearly half of the Americans infected with HIV, I am reaching out to the company to ensure that they have an accurate representation of African Americans in their upcoming trial.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News